Avenue Therapeutics, Inc. Ownership
$0.43
0.00%
Nasdaq, Oct 16, 09:30 am EDT.
Index
Industry
Avenue Therapeutics, Inc. Top Shareholders
| # | Holder | Shares | % of Shares Out | Change | Filing Date |
|---|---|---|---|---|---|
| 1 |
Fortress Biotech Inc
|
439.733k | 13.33% | +111.209k | Jan 02 2026 |
| 2 |
Ikarian Capital LLC
|
130.820k | 3.96% | +130.820k | Dec 31 2025 |
| 3 |
Rosenwald (Lindsay A)
|
4.671k | 0.14% | — | Mar 23 2026 |
| 4 |
Kranzler (Jay D)
|
559.000 | 0.02% | — | Mar 23 2026 |
| 5 |
Herskowitz (Neil)
|
97.000 | 0.00% | — | Mar 23 2026 |
|
1
Fortress Biotech Inc
|
13.33%
439.733k
|
|
2
Ikarian Capital LLC
|
3.96%
130.820k
|
|
3
Rosenwald (Lindsay A)
|
0.14%
4.671k
|
|
4
Kranzler (Jay D)
|
0.02%
559.000
|
|
5
Herskowitz (Neil)
|
0.00%
97.000
|
| The largest shareholders show who really holds influence: big institutional owners shape a stock's liquidity, and building or cutting positions can move the price. | |
| The 5 largest shareholders together hold 17.45% of Avenue Therapeutics, Inc., with Fortress Biotech Inc the biggest at 13.33%, followed by Ikarian Capital LLC (3.96%) and Rosenwald (Lindsay A) (0.14%). |
Recent Avenue Therapeutics, Inc. Insider Transactions
Powered by
| Date | Insider & Role | Type | Price | Quantity | Volume |
|---|---|---|---|---|---|
| Oct 20 2026 |
John Mitchell
CEO
|
Purchases
|
$182.45 | + 15,000 | $2,736,750 |
| Oct 17 2026 |
Sarah Chen
CFO
|
Sales
|
$179.80 | - 8,500 | $1,528,300 |
| Oct 13 2026 |
Robert Williams
COO
|
Purchases
|
$175.20 | + 12,000 | $2,102,400 |
| Oct 08 2026 |
Emily Rodriguez
Director
|
Sales
|
$181.30 | - 5,200 | $942,760 |
| Oct 02 2026 |
Michael Thompson
SVP Operations
|
Purchases
|
$170.50 | + 20,000 | $3,410,000 |
| Sep 25 2026 |
Lisa Park
General Counsel
|
Sales
|
$177.90 | - 6,800 | $1,209,720 |
| No transactions found for this filter. | |||||
|
John Mitchell
PURCHASES
|
Oct 20 2026
$182.45
|
|
Sarah Chen
SALES
|
Oct 17 2026
$179.80
|
|
Robert Williams
PURCHASES
|
Oct 13 2026
$175.20
|
|
Emily Rodriguez
SALES
|
Oct 08 2026
$181.30
|
|
Michael Thompson
PURCHASES
|
Oct 02 2026
$170.50
|
|
Lisa Park
SALES
|
Sep 25 2026
$177.90
|
| No transactions found for this filter. | |
| Insider transactions show you what executives, directors and major shareholders do with their own stock: people who know the company from the inside. Buys are the most telling signal, because insiders invest their own money. Sells are harder to read, since they can also be driven by taxes, diversification or expiring option programs. |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
